EE270 Cost-Effectiveness Analysis of Tisagenlecleucel for Third-Line Treatment With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients
Abstract
Authors
Kuan-Wei Lai Ming Yao Bor-Sheng Ko Sze-Hwei Lee Jui-Che Chen Hui-Chu Lang